INCY
$70.33
Revenue | $1052.9Mn |
Net Profits | $158.2Mn |
Net Profit Margins | 15.03% |
PE Ratio | 327.24 |
Incyte Corporation’s revenue jumped 19.53% since last year same period to $1052.9Mn in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -10.67% fall in its revenue since last 3-months.
Incyte Corporation’s net profit fell -6.69% since last year same period to $158.2Mn in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -21.37% fall in its net profits since last 3-months.
Incyte Corporation’s net profit margin fell -21.93% since last year same period to 15.03% in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -11.98% fall in its net profit margins since last 3-months.
Incyte Corporation’s price-to-earnings ratio after this Q1 2025 earnings stands at 327.24.
EPS Estimate Current Quarter | 1.53 |
EPS Estimate Current Year | 1.53 |
Incyte Corporation’s earning per share (EPS) estimates for the current quarter stand at 1.53 - a 9.29% jump from last quarter’s estimates.
Incyte Corporation’s earning per share (EPS) estimates for the current year stand at 1.53.
Earning Per Share (EPS) | 0 |
Incyte Corporation’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Incyte Corporation has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-04-29 | 0.84 | 1.16 | 38.1% |
2025-11-04 | 1.53 | 0 | -100% |